We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 4

1.
Figure 3

Figure 3. From: Identification of the first COG-CDG patient of Indian Origin.

Analysis of COG4 Exon5 mutation c.697 G/T (p.E233X) and Exon19 mutation c.2318 T/G (p.L773R) from patient CDG-0255

Bobby G. Ng, et al. Mol Genet Metab. ;102(3):364-367.
2.
Figure 2

Figure 2. From: Identification of the first COG-CDG patient of Indian Origin.

Western blot analysis of COG4 protein from a healthy control and patient CDG-0255. Actin was used as a loading control and protein densitometry were determined using IMAGE J software.

Bobby G. Ng, et al. Mol Genet Metab. ;102(3):364-367.
3.
Figure 4

Figure 4. From: Identification of the first COG-CDG patient of Indian Origin.

HPLC analysis of secreted [6-3H] galactose labeled GAP products from control and CDG-0255 patient fibroblasts. A.) Total purified GAP material B.) GAP material desialated by mild acid hydrolysis.

Bobby G. Ng, et al. Mol Genet Metab. ;102(3):364-367.
4.
Figure 1

Figure 1. From: Identification of the first COG-CDG patient of Indian Origin.

BFA-induced retrograde transport in control and lentiviral infected CDG-0255 patient fibroblasts. Cells were treated for 15 minutes with 0.25ug/ml of BFA followed by fixing the cells with 4% paraformaldehyde. The percentages of cells with Golgi remnants, as determined by the localization of the Golgi marker Giantin, were calculated by counting at least 200 cells.

Bobby G. Ng, et al. Mol Genet Metab. ;102(3):364-367.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk